Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555


Report Image
Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020
Published: May-2014    |    Formats: PDF & Excel   |   Author(s):Ranjan Singh   |   Code: DI 14175
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology
  • Analyst's
    Review
  • Sample

Pages 144
Tables 80

Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves  designing and construction of biological systems or devices that can be applied in varied domains to get specified results. It’s a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.

Assistance from government and private organizations, rising number of entities conducting research and declining cost of DNA sequencing and synthesizing are key driving factors of the market. Governments are providing funds to research organizations, assisting them to find novel applications of synthetic biology. Bio-safety & bio-security issues, ethical issues and regulations are key retraining factors of the market. The fact that synthetic biology can be misused has raised concerns all around the world. Further, there are possibilities of accidental release of pathogens or genetically modified organisms into free atmosphere.

Synthetic Biology Product Market Analysis

Synthetic Biology product market is segmented into enabling products, enabled products and core products. In 2013, enabled product segment was the largest revenue generating segment and this segment would not experience substantial market change in the coming years. Enabling product is the fastest growing segment at a CAGR of 53.7% during the forecast period. Enabling products have many applications in various fields. Advancement in the technologies require lot of issues to be addressed such as high rate of error in the self-assembly, high cost of DNA, etc. Use of enabling products can overcome these hurdles. This factor is triggering the growth of enabling products.

Synthetic Biology Technology Market Analysis

Synthetic Biology technology market is segmented into enabling technology and enabled technology. In 2013, enabled technology had generated highest revenue and it is forecast that in the coming years, this segment would continue to dominate the other segment in revenue generation. Enabling technologies segment is growing at a faster rate, and growing at a CAGR of 48.6% during the forecast period. Recent advancement in the cellular and molecular biology requires monitoring and manipulation of biological system. Use of enabling technologies results in applying engineering principles to build, manufacture, and design new biological devices and systems. This factor is triggering the growth of enabling technologies.

Synthetic Biology Application Market Analysis

Synthetic Biology application market is segmented into research & development, chemicals, agriculture, pharmaceuticals & diagnostics, biofuels and others (biotechnology and biomaterials). In 2013, pharmaceuticals & diagnostics was the largest revenue-generating segment and it is forecast that this segment would continue to dominate the other segments in revenue generation. Biofuels is the fastest growing segment at a CAGR of 85.2% during the forecast period. There is high demand for energy security, food safety and fuel generated from agriculture, which is contributing to the growth of the Biofuels market.

Synthetic Biology Geography Market Analysis

Synthetic Biology geography market is segmented into North America, Europe, Asia Pacific and RoW. In 2013, Europe was the largest revenue-generating segment and it is forecast that it would continue to dominate the other segment in generating revenue. In Europe, there were many supporting government regulations due to which it was possible to invest a lot in the synthetic biology research. These researches resulted into application of synthetic biology in various fields such as medicine, energy, environment, biological nanomachines & biosensors, chemical industry, national security. Asia- pacific is the fastest growing segment experiencing a CAGR of 46.4% during the forecast period. Asia pacific brings lot of opportunities for the growth of the Synthetic Biology market. The factors that are driving the growth of the market are large number of under nutrition population that brings in the need for increased food production. This factor results in high demand for synthetically modified crops. Rising petroleum based fuel prices are resulting in high demand for bio-diesel, which is also contributing to the growth of the synthetic biology market. In addition, raised awareness about synthetic biology market such as generation of new life, manipulation of life, etc., are also some of the factors that are unlocking the doors for the growth of the market.

Synthetic Biology Market Competitive Analysis

The strategies followed by key players in this market present a clear understanding about the intensity of concentration they are giving to a specific business segment. Strategic analysis of the companies reveals that most of the companies are concentrating on agreements followed by product launch for the expansion of their business. The agreements among the companies would enhance their operations and services. Most of the agreements were related to development of product for chemical industries, followed biofuels and synthetic genes industries. Product launches were adopted by the companies to diversify their products and explore new areas of applications. Companies adopted strategies to launch new products to diversify its approach in the chemical industry and pharmaceuticals. Companies also adopted strategies such as collaboration, joint venture and acquisition for the expansion of their business. These strategies resulted in the advancement of the technology and diversification of the products in the untapped areas. These strategies were adopted by the companies to diversify their business in the industries such as pharmaceuticals, synthetic genes, biofuels and chemicals.

Synthetic Biology Market High-Level Analysis

Porter’s five-force analysis weighs the bargaining power of buyers and suppliers including the rivalry scenario in the market. As far as core products of the market are concerned, there are few suppliers; and this fact raises the bargaining power of the suppliers. However, declining prices of DNA sequencing and synthesis may lower their bargaining power in future. Being a novel field, threat of substitute is low, as it is far better than the conventional technologies. The value chain analysis reveals that enabling products such as DNA synthesis and oligonucleotide synthesis act as building blocks for the core products and the core products are used by various industries to manufacture enabled products such as chemicals and bio-fuels. Top investment pocket analysis reveals biofuels as the most promising sector for investments in future. This market possesses huge growth potential; however, cash flow in this sector at present is comparatively low. Various petroleum and chemical companies are expected to enter this market during the forecast period.

Synthetic_biology

Key Benefits

  • Analysis of the synthetic biology market on the basis of various segments such as products, technology, application and geography is expounded in the report.  
  • To study the various factors that are enhancing and restraining the growth of the market that would help the market players in deeply understanding the market
  • Qualitative as well as quantitative analysis of the current market conditions coupled with future estimations through 2014-2020 would help stakeholders take strategic and profitable decisions
  • Geographic analysis of the market would help the companies to plan and take region based decisions
  • Porter’s five forces model helps to understand the bargaining power of buyers and suppliers and threat of the new entrants
  • Analysis of the captivating strategies adopted by the market players is conducted and that would assist the stakeholders to take actionable decisions
  • The analysis focuses on the wide variety of opportunities for the growth and expansion of the market

Reason for doing the study

Synthetic Biology is a relatively newer field, came into existence a decade ago. Many of its applications have recently entered the commercial market. Other potential applications would see commercialization in near future. As the market holds huge potential in future and has widespread applications, namely in industries such as chemical, pharmaceuticals, fuels, agricultural, healthcare, etc., the understanding of the market beforehand will give an upper hand to the stakeholders.

Key Deliverables

Market by Products

  • Enabling Products
    • DNA Synthesis
    • Oligonucleotide Synthesis
  • Enabled Products
    • Pharmaceuticals
    • Chemicals
    • Biofuels
    • Agriculture
  • Core Products
    • Synthetic DNA
    • Synthetic Genes
    • Synthetic Cells
    • XNA
    • Chassis Organisms 

Market by Technology

  • Enabling Technology
    • Genome Engineering
    • Microfluidics technologies
    • DNA synthesis & sequencing technologies
    • Bioinformatics technologies
    • Biological components and integrated systems technologies
  • Enabled Technology
    • Pathway engineering
    • Synthetic microbial consortia
    • Biofuels technologies

Market by Application

  • Research & Development
  • Chemicals
  • Agriculture
  • Pharmaceuticals & Diagnostics
  • Biofuels
  • Others (Environment, Biotechnology & Biomaterials, etc.)

Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • RoW

TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key Benefits
1.3 Reason for doing the study
1.4 Key Market Segments
1.5 Research Methodology

1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Segment Analysis
2.2 Market beyond: what to expect by 2025

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top Factors Impacting synthetic biology market
3.2.2 Top investment pockets
3.2.3 Top winning strategies

3.3 Porters five force analysis

3.3.1 Fewer suppliers lead to higher bargaining power of suppliers
3.3.2 High demand leads to low buyer power
3.3.3 Innovative technology leads to low threat of substitute
3.3.4 Diverse application raises threat of new entrants
3.3.5 Competitive rivalry to be maintained due high exit barriers

3.4 Value chain analysis

3.4.1 Research
3.4.2 Testing
3.4.3 Manufacturing
3.4.4 Applications area

3.5 Policies and regulations
3.6 Concerns raised by synthetic biology
3.7 Case Studies

3.7.1 Case Study 1: Sourcing of fragrance from cured seed pod of vanilla orchid
3.7.2 Case Study 2: Trial of new synthetic biology technique to boost biodiesel production
3.7.3 Case Study 3: Potential impacts of synthetic biology on economy and livelihood

3.8 Market Dynamics (Synthetic Biology as a whole)

3.8.1 Drivers

3.8.1.1 Funding and Assistance from government and private organizations
3.8.1.2 Rising number of entities conducting research
3.8.1.3 Rising number of companies entering the market
3.8.1.4 Declining cost of DNA Sequencing

3.8.2 Restraints

3.8.2.1 Bio-safety and Bio-security Issues
3.8.2.2 Ethical challenges and formation of strict regulatory bodies

3.8.3 Opportunities

3.8.3.1 rising demand for bio-fuels
3.8.3.2 Rising economies of Asia Pacific
3.8.3.3 Increasing investments of WHO and other NGOs in developing countries

CHAPTER 4 OVERVIEW OF DNA SYNTHESIS

4.1 Technological trends in DNA synthesis
4.2 Commercial application scope for large DNA constructs in Europe and North America

4.2.1 Antibody engineering
4.2.2 Metabolic engineering
4.2.3 Pathway engineering
4.2.4 Other potential application (as a core products)

4.3 Top players positing, 2013, (Focus on DNA Synthesis)
4.4 Market Dynamics specific to DNA synthesis

4.4.1 Drivers

4.4.1.1 Technical advancements of integrated sequencing
4.4.1.2 Growing demand for large DNA constructs
4.4.1.3 Increasing accountability of government funding

4.4.2 Restraints

4.4.2.1 High cost and longer duration of DNA synthesis
4.4.2.2 Absence of regulatory guidelines

4.4.3 Opportunities

4.4.3.1 Exploring opportunities in European countries

CHAPTER 5 GLOBAL SYNTHETIC BIOLOGY MARKET BY PRODUCT

5.1 Global synthetic biology market by product
5.2 Enabling Products

5.2.1 Global synthetic biology market by enabling products
5.2.2 DNA synthesis

5.2.2.1 synthetic biology DNA Synthesis market by Geography

5.2.3 Oligonucleotide synthesis

5.2.3.1 synthetic biology Oligonucleotide Synthesis market by Geography

5.3 Core Products

5.3.1 Global synthetic biology market by core products
5.3.2 Synthetic DNA

5.3.2.1 synthetic biology Synthetic DNA market by Geography

5.3.3 Synthetic Genes

5.3.3.1 Global synthetic biology Synthetic genes market by geography

5.3.4 Synthetic Cells

5.3.4.1 synthetic biology Synthetic cells market by Geography

5.3.5 XNA (Xeno Nucleic Acid)

5.3.5.1 synthetic biology xna market by geography

5.3.6 Chassis Organisms

5.3.6.1 SYNTHETIC biology Chassis organisms market by Geography

5.4 Enabled Products

5.4.1 Global synthetic biology market by enabled products
5.4.2 Pharmaceuticals and Diagnostics

5.4.2.1 synthetic biology Pharmaceuticals and diagnostics market by geography

5.4.3 Chemicals

5.4.3.1 synthetic biology chemicals market by geography

5.4.4 Biofuels

5.4.4.1 synthetic biology biofuels market by geography

5.4.5 Agriculture

5.4.5.1 synthetic biology agriculture market by Geography

CHAPTER 6 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGIES

6.1 Global synthetic biology market by technologies
6.2 Enabling technologies

6.2.1 Global synthetic biology enabling technologies market by type
6.2.2 Genome Engineering

6.2.2.1 synthetic biology genome engineering market by Geography

6.2.3 Microfluidics technologies

6.2.3.1 synthetic biology Microfluidics technologies market by geography
6.2.3.2 DNA Microarrays - Oligo Synthesis

6.2.4 DNA Synthesis and sequencing

6.2.4.1 synthetic biology DNA Synthesis and sequencing market by geography
6.2.4.2 DNA synthesis technologies
6.2.4.3 DNA sequencing technologies

6.2.5 Bioinformatics technologies

6.2.5.1 synthetic biology bioinformatics technologies market by Geography

6.2.6 Biological components and integrated systems technologies

6.2.6.1 synthetic biology biological components and integrated systems technologies market by Geography
6.2.6.2 Synthetic genes
6.2.6.3 Biobrick parts
6.2.6.4 Minimal genomes and chassis organisms

6.3 Enabled Technologies

6.3.1 Global synthetic biology market by enabled technologies
6.3.2 Pathway engineering

6.3.2.1 Synthetic biology pathway engineering market by geography

6.3.3 Synthetic microbial consortia

6.3.3.1 synthetic biology synthetic microbial consortia market by geography

6.3.4 Biofuels technologies

6.3.4.1 synthetic biology biofuel technologies market by geography

CHAPTER 7 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATION

7.1 Global synthetic biology market by application
7.2 Research & Development

7.2.1 Synthetic biology research & development market by geography

7.3 Chemicals industry

7.3.1 Synthetic biology chemical industry market by geography

7.4 Agriculture

7.4.1 Synthetic biology agriculture market by geography

7.5 Pharmaceuticals & diagnostics

7.5.1 Synthetic biology pharmaceuticals & diagnostics market by geography
7.5.2 Pharmaceuticals
7.5.3 Diagnostics

7.6 Biofuels industry

7.6.1 Synthetic biology biofuels market by geography

7.7 Others (biotechnology, environment, biomaterials and so on)

7.7.1 Synthetic biology other applications market by geography

CHAPTER 8 SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY

8.1 North America

8.1.1 North America synthetic biology market

8.2 Europe

8.2.1 European Synthetic biology market

8.3 Asia Pacific

8.3.1 Asia Pacific synthetic biology market by application

8.4 RoW

8.4.1 RoW synthetic biology market by application

CHAPTER 9 COMPANY PROFILES

9.1 BASF

9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Business Performance
9.1.4 Strategic moves and developments

9.1.4.1 Principal Strategies: Agreements

9.1.5 Swot analysis of BASF

9.2 GEN9 Inc.

9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business Performance
9.2.4 Strategic moves and developments

9.2.4.1 Principal Strategies: Product LAunches

9.2.5 Swot analysis of Gen9 Inc.

9.3 Algenol Biofuels

9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business Performance
9.3.4 Strategic moves and developments

9.3.4.1 Principal Strategies: Agreements

9.3.5 Swot analysis of Algenol Biofuels

9.4 Codexis Inc.

9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business Performance
9.4.4 Strategic moves and developments

9.4.4.1 Principal Strategies: Agreements
9.4.4.2 Secondary strategies: Product launch

9.4.5 Swot analysis of Codexis

9.5 GenScript Corporation

9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business Performance
9.5.4 Strategic moves and developments

9.5.4.1 Principal Strategies: Product Launch
9.5.4.2 Secondary Strategies: Agreements

9.5.5 Swot analysis of GenScript

9.6 DuPont

9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Business Performance
9.6.4 Strategic moves and developments

9.6.4.1 Principal Strategies: Agreements

9.6.5 Swot analysis of DuPont

9.7 Butamax Advanced Biofuels

9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Strategic moves and developments

9.7.3.1 Principal Strategies: Agreements

9.7.4 Swot analysis of Butamax Advanced Biofuels

9.8 BioAmber

9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business Performance
9.8.4 Strategic moves and developments

9.8.4.1 Principal Strategies: Partnership

9.8.5 Swot analysis of BioAmber

9.9 Biosearch Technologies, Inc.

9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Strategic moves and developments

9.9.3.1 Principal Strategies: Acquisition
9.9.3.2 Secondary strategies: Agreement & Product launch

9.9.4 Swot analysis of Biosearch

9.10 OriGene Technologies, Inc.

9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Strategic moves and developments

9.10.3.1 Principal Strategies: Acquisition
9.10.3.2 Secondary strategies: Product launch

9.10.4 Swot analysis of OriGene

9.11 Synthetic Genomics, Inc.

9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Strategic moves and developments

9.11.3.1 Principal Strategies: Agreements
9.11.3.2 Secondary strategies: Collaboration

9.11.4 Swot analysis of Synthetic Genomics

9.12 GeneArt (Life Technologies)

9.12.1 Overview
9.12.2 Service portfolio of GeneArt (Life Technologies)
9.12.3 Key strategies
9.12.4 SWOT analysis of GeneArt (Life Technologies)

9.13 GENEWIZ, Inc.

9.13.1 Company overview
9.13.2 Services Portfolio
9.13.3 SWOT analysis of GENEWIZ, Inc.

9.14 Eurofins Scientific, Inc.

9.14.1 Company overview
9.14.2 Services portfolio
9.14.3 Strategic moves and developments

9.14.3.1 Principal Strategies

9.14.4 SWOT analysis of Eurofins Scientific, Inc.

9.15 Integrated DNA Technologies, Inc.

9.15.1 Company overview
9.15.2 Services Portfolio
9.15.3 Strategic moves and developments

9.15.3.1 Principal Strategies
9.15.3.2 Secondary Strategies

9.15.4 SWOT analysis of Integrated DNA Technologies, Inc.

9.16 DNA2.0, Inc.

9.16.1 Company overview
9.16.2 Services portfolio
9.16.3 Strategic moves and developments

9.16.3.1 Principal Strategies
9.16.3.2 Secondary Strategies

9.16.4 SWOT analysis of DNA2.0, Inc.

9.17 Pareto Biotechnologies

9.17.1 Company overview
9.17.2 Services Portfolio
9.17.3 Strategic moves and developments

9.17.3.1 Principal Strategies
9.17.3.2 Secondary Strategies

9.17.4 SWOT analysis of Parento Biotechnologies

9.18 Synthorx, Inc.

9.18.1 Company overview
9.18.2 Services Portfolio
9.18.3 SWOT analysis of Synthorx, Inc.

9.19 TeselaGen Biotechnology

9.19.1 Company overview
9.19.2 Services Portfolio
9.19.3 Strategic moves and developments

9.19.3.1 Principal Strategy
9.19.3.2 Secondary Strategy

9.19.4 SWOT Analysis of TeselaGen Biotechnology.

9.20 Editas Medicine, Inc.

9.20.1 Company overview
9.20.2 Services Portfolio
9.20.3 Strategic moves and development

9.20.3.1 Principal Strategy
9.20.3.2 Secondary Strategy

9.20.4 SWOT analysis of Editas Medicine, Inc.

9.21 Twist Bioscience

9.21.1 Company overview
9.21.2 Services portfolio
9.21.3 Strategic moves and developments

9.21.3.1 Principle Strategy

9.21.4 SWOT analysis of Twist Bioscience

9.22 GeneWorks Pty Ltd.

9.22.1 Company overview
9.22.2 Services portfolio
9.22.3 SWOT analysis of GeneWorks Pty. Ltd.

9.23 Proterro, Inc.

9.23.1 Company overview
9.23.2 Services portfolio
9.23.3 Strategic moves and developments

9.23.3.1 Principle Strategy

9.23.4 SWOT analysis of Proterro, Inc.

9.24 Blue heron (OriGene technologies Inc.)

9.24.1 Overview
9.24.2 Service portfolio of Blue heron (OriGene technologies Inc.)
9.24.3 SWOT analysis of Blue heron (OriGene technologies Inc.)

LIST OF TABLES

TABLE 1  SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 2  SYNTHETIC BIOLOGY MARKET MODERATE GROWTH SCENARIO BY GEOGRAPHY, BASE CASE, 2020 – 2025 ($MILLION)
TABLE 3  SYNTHETIC BIOLOGY MARKET RAPID GROWTH SCENARIO BY GEOGRAPHY, 2020 – 2025 ($MILLION)
TABLE 4  NORTH AMERICA SYNTHETIC BIOLOGY MARKET DIMINISHING GROWTH SCENARIO BY GEOGRAPHY, 2020 – 2025 ($MILLION)
TABLE 5  COMMERCIAL APPLICATION OF SYNTHETIC BIOLOGY IN DERIVING RENEWABLE ENERGY
TABLE 6  GLOBAL SYNTHETIC BIOLOGY MARKET BY PRODUCT, 2013 – 2020 ($MILLION)
TABLE 7  GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLING PRODUCTS, 2013 – 2020 ($MILLION)
TABLE 8  SYNTHETIC BIOLOGY DNA SYNTHESIS MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 9  GLOBAL SYNTHETIC BIOLOGY MARKET BY OLIGONUCLEOTIDE SYNTHESIS, 2013 – 2020 ($MILLION)
TABLE 10  GLOBAL SYNTHETIC BIOLOGY MARKET BY CORE PRODUCTS, 2013 – 2020 ($MILLION)
TABLE 11  SYNTHETIC BIOLOGY SYNTHETIC DNA MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 12  GLOBAL SYNTHETIC BIOLOGY MARKET BY SYNTHETIC GENES, 2013 – 2020 ($MILLION)
TABLE 13  GLOBAL SYNTHETIC BIOLOGY SYNTHETIC CELLS MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 14  GLOBAL SYNTHETIC BIOLOGY MARKET BY XNA, 2013 – 2020 ($MILLION)
TABLE 15  SYNTHETIC BIOLOGY CHASSIS ORGANISMS MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 16  GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLED PRODUCTS, 2013 – 2020 ($MILLION)
TABLE 17  SYNTHETIC BIOLOGY PHARMACEUTICALS AND DIAGNOSTICS MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 18  SYNTHETIC BIOLOGY CHEMICALS MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 19  SYNTHETIC BIOLOGY BIOFUELS MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 20  SYNTHETIC BIOLOGY AGRICULTURE MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 21  GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGIES, 2013 – 2020 ($MILLION)
TABLE 22  GLOBAL SYNTHETIC BIOLOGY ENABLING TECHNOLOGIES MARKET BY TYPE, 2013 – 2020 ($MILLION)
TABLE 23  SYNTHETIC BIOLOGY GENOME ENGINEERING MARKET BY GEOGRAPHY 2013 – 2020 ($MILLION)
TABLE 24  SYNTHETIC BIOLOGY MICROFLUIDICS TECHNOLOGIES MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 25  SYNTHETIC BIOLOGY DNA SYNTHESIS AND SEQUENCING MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 26  SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 27  SYNTHETIC BIOLOGY BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS TECHNOLOGIES MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 28  GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLED TECHNOLOGIES, 2013 – 2020 ($MILLION)
TABLE 29  SYNTHETIC BIOLOGY PATHWAY ENGINEERING MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 30  SYNTHETIC BIOLOGY SYNTHETIC MICROBIAL CONSORTIA MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 31  GLOBAL SYNTHETIC BIOLOGY MARKET BY BIOFUEL TECHNOLOGIES, 2013 – 2020 ($MILLION)
TABLE 32  GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 – 2020 ($MILLION)
TABLE 33  GLOBAL SYNTHETIC BIOLOGY MARKET BY RESEARCH AND DEVELOPMENT, 2013 – 2020 ($MILLION)
TABLE 34  SYNTHETIC BIOLOGY CHEMICAL INDUSTRY MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 35  SYNTHETIC BIOLOGY AGRICULTURE MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 36  SYNTHETIC BIOLOGY PHARMACEUTICALS & DIAGNOSTICS MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 37  SYNTHETIC BIOLOGY BIOFUELS MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 38  SYNTHETIC BIOLOGY OTHER APPLICATIONS MARKET BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 39  NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
TABLE 40  EUROPE SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
TABLE 41  ASIA PACIFIC SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
TABLE 42  ROW SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
TABLE 43  BASF SNAPSHOT
TABLE 44  BUSINESS REVENUES BY SECTORS (2013)
TABLE 45  GEN9INC. SNAPSHOT
TABLE 46  ALGENOL SNAPSHOT
TABLE 47  CODEXIS SNAPSHOT
TABLE 48  GENSCRIPT SNAPSHOT
TABLE 49  DUPONT SNAPSHOT
TABLE 50  BUTAMAX ADVANCED BIOFUELS
TABLE 51  BIOAMBER SNAPSHOT
TABLE 52  BIOSEARCH SNAPSHOT
TABLE 53  ORIGENE SNAPSHOT
TABLE 54  SYNTHETIC GENOMICS SNAPSHOT
TABLE 55  COMPANY SNAPSHOT OF GENEART (LIFE TECHNOLOGIES)
TABLE 56  SERVICE PORTFOLIO OF GENEART AG (LIFE TECHNOLOGIES)
TABLE 57  COMPANY SNAPSHOT OF GENEWIZ, INC.
TABLE 58  SERVICES PORTFOLIO OF GENEWIZ, INC
TABLE 59  COMPANY SNAPSHOT OF EUROFINS SCIENTIFIC, INC.
TABLE 60  SERVICE PORTFOLIO OF EUROFINS SCIENTIFIC,INC.
TABLE 61  COMPANY SNAPSHOT OF INTEGRATED DNA TECHNOLOGIES, INC
TABLE 62  SERVICES PORTFOLIO OF INTEGRATED DNA TECHNOLOGIES, INC.
TABLE 63  COMPANY SNAPSHOT OF DNA2.0, INC.
TABLE 64  SERVICES PORTFOLIO OF DNA2.0, INC.
TABLE 65  COMPANY SNAPSHOT OF PARENTO BIOTECHNOLOGIES
TABLE 66  SERVICES PORTFOLIO OF PARENTO BIOTECHNOLOGIES
TABLE 67  COMPANY SNAPSHOT OF SYNTHORX, INC.
TABLE 68  SERVICES PORTFOLIO OF SYNTHORX, INC.
TABLE 69  COMPANY SNAPSHOT OF TESELAGEN BIOTECHNOLOGY
TABLE 70  SERVICES PORTFOLIO OF TESELAGEN BIOTECHNOLOGY
TABLE 71  COMPANY SNAPSHOT OF EDITAS MEDICINE, INC.
TABLE 72  SERVICES PORTFOLIO OF EDITAS MEDICINE, INC.
TABLE 73  COMPANY SNAPSHOT OF TWIST BIOSCIENCE
TABLE 74  SERVICES PORTFOLIO OF TWIST BIOSCIENCE
TABLE 75  COMPANY SNAPSHOT OF GENEWORKS PTY. LTD.
TABLE 76  SERVICES PORTFOLIO OF GENEWORKS PTY. LTD.
TABLE 77  COMPANY SNAPSHOT OF PROTERRO, INC.
TABLE 78  SERVICES PORTFOLIO OF PROTERRO, INC.
TABLE 79  COMPANY SNAPSHOT OF BLUE HERON (ORIGENE TECHNOLOGIES INC.)
TABLE 80  SERVICE PORTFOLIO OF BLUE HERON (ORIGENE TECHNOLOGIES INC.)

LIST OF FIGURES

FIG. 1  TOP IMPACTING FACTORS, MODERATE GROWTH SCENARIO (2020 - 2025)
FIG. 2  TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020 - 2025)
FIG. 3  TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020 - 2025)
FIG. 4  TOP FACTORS IMPACTING MARKET SYNTHETIC BIOLOGY MARKET
FIG. 5  TOP INVESTMENT POCKETS IN SYNTHETIC BIOLOGY APPLICATION MARKET
FIG. 6  TOP WINNING STRATEGIES FOLLOWED BY KEY PLAYERS (2011-2014)
FIG. 7  PORTERS FIVE FORCE ANALYSIS
FIG. 8  VALUE CHAIN ANALYSIS
FIG. 9  WORLDWIDE MAJOR ENTITIES CONDUCTING RESEARCH IN SYNTHETIC BIOLOGY (2009-2013)
FIG. 10  TOP PLAYERS POSITING OF SYNTHETIC BIOLOGY MARKET (2013)
FIG. 11  COST PER RAW MEGABASE OF DNA SEQUENCE
FIG. 12  WORLD BIODIESEL PRODUCTION AND CAPACITY
FIG. 13  NUMBER OF ENTITIES CONDUCTING RESEARCH IN STATES OF THE U.S.
FIG. 14  BIOFUEL PRODUCTION BY MAJOR REGIONS (2011 – 2020)
FIG. 15  MAJOR ENTITIES CONDUCTING RESEARCH IN THE U.S.
FIG. 16  MAJOR ENTITIES CONDUCTING RESEARCH IN EUROPE
FIG. 17  TOP SUGAR EXPORTERS 2012 (MILLION TONS)
FIG. 18  FINANCIAL REVENUES BY GEOGRAPHY (2013)
FIG. 19  SWOT ANALYSIS OF BASF
FIG. 20  SWOT ANALYSIS OF GEN9INC.
FIG. 21  SWOT ANALYSIS OF ALGENOL BIOFUELS
FIG. 22  SWOT ANALYSIS OF CODEXIS
FIG. 23  SWOT ANALYSIS OF GENSCRIPT
FIG. 24  SALES BY SEGMENTS (2013)
FIG. 25  SALES BY REGION (2013)
FIG. 26  SWOT ANALYSIS OF DUPONT
FIG. 27  SWOT ANALYSIS OF BUTAMAX ADVANCED BIOFUELS
FIG. 28  SWOT ANALYSIS OF BIOAMBER
FIG. 29  SWOT ANALYSIS OF BIOSEARCH
FIG. 30  SWOT ANALYSIS OF BIOSEARCH
FIG. 31  SWOT ANALYSIS OF SYNTHETIC GENOMICS
FIG. 32  SWOT ANALYSIS OF GENEART (LIFE TECHNOLOGIES)
FIG. 33  SWOT ANALYSIS OF GENEWIZ, INC.
FIG. 34  SWOT ANALYSIS OF EUROFINS SCIENTIFIC, INC.
FIG. 35  SWOT ANALYSIS OF INTEGRATED DNA TECHNOLOGIES, INC.
FIG. 36  SWOT ANALYSIS OF DNA2.0, INC.
FIG. 37  SWOT ANALYSIS OF PARENTO BIOTECHNOLOGIES
FIG. 38  SWOT ANALYSIS OF SYNTHORX, INC.
FIG. 39  SWOT ANALYSIS OF TESELAGEN BIOTECHNOLOGY.
FIG. 40  SWOT ANALYSIS OF EDITAS MEDICINE, INC.
FIG. 41  SWOT ANALYSIS OF TWIST BIOSCIENCE
FIG. 42  SWOT ANALYSIS OF GENEWORKS PTT. LTD.
FIG. 43  SWOT ANALYSIS OF PROTERRO, INC.
FIG. 44  SWOT ANALYSIS OF BLUE HERON (ORIGENE TECHNOLOGIES INC.) 

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Number of entities conducting research in the field of synthetic biology is rising enormously. During 2009 to 2013, number of companies and universities conducting such researches has risen from 61 to 192 and 127 to 204 respectively. Since the last score, cost of DNA sequencing has seen a drastic and continuous fall. This is acting as a strong factor paving way for the synthetic biology market in developing countries. Further, rise in funding by government bodies and private organizations is propelling the market growth.

On the contrary, ethical, bio-safety and security concerns are giving a bumpy ride to the market. However, these issues would be resolved with rising awareness among people and technological advances to increase the safety in synthetic biology processes. In future, the impact of the key factors influencing the market is expected to experience a change in intensity; however, the pace with which the market is growing will be maintained during the estimation period.  

Synthetic biology is a new trend in the field of biotechnology and molecular biology. This has raised the bargaining power of the suppliers of core products (DNA synthesis and oligonucleotide synthesis) due to rise in demand, favored by ongoing researches in this domain. However, declining DNA synthesis and sequencing prices would lower the bargaining power of the suppliers in the due course. The demand for enabled products such as bio-fuels, chemicals, drugs and fertilizers is expected to rise with increasing acceptance of synthetic biology products and this would give a thrust to the bargaining power of enabled product suppliers during the forecast period.

Supposedly, the bio-fuel industry would undergo a paradigm shift from the present fuel manufacturing technique to the synthetic biology processes. As per International Energy Agency (IEA), worldwide transportation fuel will have a 27% share from bio fuels by 2050. Bio-fuels are expecting tremendous growth due to rising inclination of governments and consumers towards bio-based products. In terms of geography, Asia Pacific is the fastest growing market that is assisted by improved economic conditions, which would allow investments in research and development. However, Europe would continue to lead the market throughout the analysis period due to due to huge investment in the research.

SIMILAR MARKET STUDIES

Published Reports

Imaging modalities emerged as a preferred option for the clinical industry, especially in preclinical studies. Many of the imaging technologies have been translated into micro level tools that include micro MRI, micro CT and micro PET. Apart from these technologies, micro ultrasound imaging, micro-magnetic resonance imaging (MRI), optical Imaging such as bioluminescence and fluorescence imaging, and multimodal imaging technologies have gained traction in the market.
4 Feb 2015 | Price: $3300(SU) | View Details >>

Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. These medicines find applicability in wide range of degenerative disorders including dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers are engaged in developing technologies based on biologics, genes, somatic as well as stem cells.
30 Jun 2014 | Price: $4515(SU) | View Details >>

DNA diagnostics is a cutting edge method which is set to revolutionize the field of medical diagnostics. This technique enables medical professionals to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same. It is also used for clinical diagnostic confirmation and in prenatal diagnostics.
27 Aug 2014 | Price: $4515(SU) | View Details >>

The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020. Bioinformatics is an interdisciplinary field that is used in the development and storage of data, thus helping in the analysis, organization and retrieval of the biological data. Bioinformatics has various applications and thus forms part of almost all the fields in biology. Bioinformatics form a part of agriculture, animal breeding, molecular medicine, preventive medicine, etc. The major factors driving the bioinformatics market is the need for integrated data, rising demand for drug development and discovery, the increasing focus in genomics & proteomics and the favorable government initiatives.
28 May 2014 | Price: $4515(SU) | View Details >>

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the fastest growing region. The key drivers for this market are the increase in the discovery of biomarkers and co-development of drug and corresponding diagnostic. However, cost associated with developing drugs could impede the growth of this market.
10 Jun 2014 | Price: $4515(SU) | View Details >>

Upcoming Reports

A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter to produce immune response against disease. DNA vaccines are basically the third generation vaccines that are specifically designed to overcome the unsought properties of conventional vaccines. The increasing vulnerability of population to infectious diseases and increasing number of antibiotics resistant pathogens have created the need for effective and low-cost vaccination, which would provide long lasting immunity.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Diagnostic Imaging is a technique used to examine the internal environment of the body. It helps in diagnosis and monitoring the progression of diseases. The evolution of diagnostic imaging techniques, has played a vital role in the development of healthcare industry. The diagnostic imaging market is flourished by innovations, such as ultra-fast and digital devices. It is yet imperative to find better economic alternatives which would help in the early diagnosis of disease.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Testing of blood is one of the oldest and most widely used techniques to rule out the presence of any disease. Blood tests are used to assure the biochemical and physiological well-being of the humans. They are also used to confirm the proper functioning of vital organs such as liver, kidney and thyroid and to understand the effectiveness of given therapeutics. The technological innovations along with consistent demand for better blood testing technologies have intensified the global competition. The market is growing owing to the burgeoning demand for point-of-care and minimally invasive testing devices.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Blood plasma is the liquid component of blood constituting the extracellular matrix. Blood plasma plays a crucial role in maintaining the electrolyte and osmotic balance whilst preventing infection and blood disorders in the body. It primarily consists of water along with other components such as immunoglobulin, dissolved proteins, glucose, clotting factors, electrolytes and hormones.
Price: $4515 | Pre Book Price: $3950 | View Details >>
First time Buyer ?
Check offer and
discount on this report


Get Discount

NEED MORE INFORMATION?
Call
+1 617 674 4143


Purchase Enquiry

PURCHASE OPTIONS

Single User
By obtaining a Single User License, you and your organization concur that only an individual uses this report either electronically or online. The right to use or stockpiling of the report should be confined only to one authorized computer. User will have authorization to print one duplicate of the report for individual use, yet may not be replicated for circulation. Additional copies for this report may also be order at discounted price for use by addition readers/users.
$4515

Multi User 
Multi-User license permits you to access the report from eight authorized computers. It does not permit you to display it on your company website and permits you to only print 5 copies of the report that shall not be reproduced for circulation.
$7515

Corporate  
With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report in is prohibited without the prior permission of Allied Market Research. The publisher will, in turn, regard the privacy of the purchaser and will keep it confidential. Upon buying single or multi-user license, buyer must provide the names and email ids of the authorized users of this report.
$10515


Not Interested in buying complete report?
To check the cost of chapters
WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader







Top